Adma Biologics reported $42.8M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Adma Biologics USD 42.8M 5.72M Jun/2025
Alnylam Pharmaceuticals USD -16199000 34.28M Jun/2025
Dynavax Technologies USD 10.86M 34.49M Jun/2025
Takeda JPY 184.56B 259.5B Jun/2025